XML 41 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Derivative Instruments, Hedging Activities and Fair Value (Tables)
9 Months Ended
Sep. 30, 2017
Derivative Instruments, Hedging Activities And Fair Value Disclosure [Abstract]  
Schedule of fair value of outstanding derivative contracts
The fair value of outstanding derivative contracts recorded as assets and liabilities on the Condensed Consolidated Balance Sheets was as follows:
 
 
Asset Derivatives
 
Liability Derivatives
(In thousands)
 
Balance Sheet Location
 
Fair Value
 
Balance Sheet Location
 
Fair Value
September 30, 2017
 
 
 
 
 
 
 
 
Derivatives designated as hedging instruments:
Foreign currency exchange forward contracts
 
Other current assets
 
$
2,673

 
Other current liabilities
 
$
92

Cross-currency interest rate swaps
 
Other current assets
 
110

 

 

Interest rate swaps
 

 

 
Other current liabilities
 
197

Interest rate swaps
 
Other assets
 
92

 
Other liabilities
 
2,773

Total derivatives designated as hedging instruments
 
 
 
$
2,875

 
 
 
$
3,062

Derivatives not designated as hedging instruments:
Foreign currency exchange forward contracts
 
Other current assets
 
$
572

 
Other current liabilities
 
$
22,698

 
 
Asset Derivatives
 
Liability Derivatives
(In thousands)
 
Balance Sheet Location
 
Fair Value
 
Balance Sheet Location
 
Fair Value
December 31, 2016
 
 
 
 
 
 
 
 
Derivatives designated as hedging instruments:
Foreign currency exchange forward contracts
 
Other current assets
 
$
473

 
Other current liabilities
 
$
166

Cross-currency interest rate swaps
 
Other current assets
 
514

 

 

Total derivatives designated as hedging instruments
 
 
 
$
987

 
 
 
$
166

Derivatives not designated as hedging instruments:
Foreign currency exchange forward contracts
 
Other current assets
 
$
4,459

 
Other current liabilities
 
$
3,372


Schedule of effect of derivative instruments
The effect of derivative instruments on the Condensed Consolidated Statements of Operations and the Condensed Consolidated Statements of Comprehensive Income (Loss), was as follows:
Derivatives Designated as Hedging Instruments
(In thousands)
 
Amount 
Recognized in Other
Comprehensive
Income  (“OCI”)  on Derivative -
Effective  Portion
 
Location of Amount Reclassified
from Accumulated
OCI into Income -
Effective Portion
 
Amount
Reclassified  from
Accumulated OCI into  Income -
Effective  Portion
 
Location of Amount Recognized  in Income on  Derivative - Ineffective Portion
and Amount
Excluded from
Effectiveness Testing
 
Amount  Recognized  in Income  on Derivative - Ineffective  Portion and  Amount
Excluded from
Effectiveness  Testing
 
Three Months Ended September 30, 2017:
Foreign currency exchange forward contracts
 
$
2,333

 

 
$

 
 
 
$

 
Interest rate swaps
 
(335
)
 
 
 

 
 
 

 
Cross-currency interest rate swaps
 
(72
)
 
Interest expense
 
252

 
Cost of services and products sold
 
(103
)
(a)
 
 
$
1,926

 
 
 
$
252

 
 
 
$
(103
)
 
Three Months Ended September 30, 2016:
Foreign currency exchange forward contracts
 
$
2,378

 

 
$

 

 
$

 
Cross-currency interest rate swaps
 
(210
)
 
Interest expense
 
254

 
Cost of services and products sold
 
(232
)
(a)
 
 
$
2,168

 
 
 
$
254

 
 
 
$
(232
)
 

(In thousands)
 
Amount
Recognized in  OCI  on Derivative -
Effective  Portion
 
Location Amount
Reclassified
from Accumulated
OCI into Income -
Effective Portion
 
Amount
Reclassified  from
Accumulated  OCI into  Income -
Effective  Portion
 
Location of Amount Recognized  in Income on  Derivative - Ineffective Portion
and Amount
Excluded from
Effectiveness Testing
 
Amount  Recognized  in Income  on Derivative - Ineffective  Portion and  Amount
Excluded from
Effectiveness  Testing
 
Nine Months Ended September 30, 2017:
Foreign currency forward exchange contracts
 
$
3,096

 
Product revenues / Cost of services and products sold
 
$
(185
)
 
 
 
$

 
Interest rate swaps
 
(2,878
)
 
 
 

 
 
 

 
Cross currency interest rate swaps
 
(195
)
 
Interest expense
 
745

 
Cost of services and products sold
 
(420
)
(a)
 
 
$
23

 
 
 
$
560

 
 
 
$
(420
)
 
Nine Months Ended September 30, 2016:
Foreign currency forward exchange contracts
 
$
1,748

 
Product revenues / Cost of services and products sold
 
$
(409
)
 

 
$

 
Cross currency interest rate swaps
 
(2,361
)
 
Interest expense
 
478

 
Cost of services and products sold
 
3,987

(a)
 
 
$
(613
)
 
 
 
$
69

 
 
 
$
3,987

 
(a) These gains (losses) offset foreign currency fluctuation effects on the debt principal.

Derivatives Not Designated as Hedging Instruments
 
 
Location of Gain
(Loss) Recognized in
Income on Derivative
 
Amount of Gain (Loss) Recognized in
Income on Derivative for the
Three Months Ended September 30 (b)
(In thousands)
 
 
2017
 
2016
Foreign currency exchange forward contracts
 
Cost of services and products sold
 
$
(7,025
)
 
$
552


 
 
Location of Gain
(Loss) Recognized in
Income on Derivative
 
Amount of Gain (Loss) Recognized in
Income on Derivative for the
Nine Months Ended September 30 (b)
(In thousands)
 
 
2017
 
2016
Foreign currency forward exchange contracts
 
Cost of services and products sold
 
$
(18,764
)
 
$
2,292


(b)  These gains (losses) offset amounts recognized in cost of services and products sold principally as a result of intercompany or third party foreign currency exposures.
Summary of notional amount of foreign currency exchange contracts and cross-currency interest rate swaps
The following table indicates the notional amounts of the Company's interest rate swaps at September 30, 2017:
 
 
 Annual
Notional Amount
 
Interest Rates
(In millions)
 
 
Receive
 
Pay
Maturing 2018 through 2021
 
$
300.0

 
Floating U.S. dollar rate
 
Fixed U.S. dollar rate
Cross-Currency Interest Rate Swaps (CCIRs)
The Company uses CCIRs in conjunction with certain debt issuances in order to secure a fixed local currency interest rate.  Under these CCIRs, the Company receives interest based on a fixed or floating U.S. dollar rate and pays interest on a fixed local currency rate based on the contractual amounts in dollars and the local currency, respectively.  At maturity, there is also the payment of principal amounts between currencies. The CCIRs are recorded on the Condensed Consolidated Balance Sheets at fair value, with changes in value attributed to the effect of the swaps’ interest spread and changes in the credit worthiness of the counter-parties recorded in Accumulated other comprehensive loss.  Changes in value attributed to the effect of foreign currency fluctuations are recorded on the Condensed Consolidated Statements of Operations and offset currency fluctuation effects on the debt principal.

The following table indicates the contractual amounts of the Company's CCIRs at September 30, 2017:
 
 
 
 
Interest Rates
(In millions)
 
Contractual Amount
 
Receive
 
Pay
Maturing 2017
 
$
0.7

 
Floating U.S. dollar rate
 
Fixed rupee rate
The following tables summarize, by major currency, the contractual amounts of the Company’s foreign currency exchange forward contracts in U.S. dollars.  The “Buy” amounts represent the U.S. dollar equivalent of commitments to purchase foreign currencies, and the “Sell” amounts represent the U.S. dollar equivalent of commitments to sell foreign currencies.  The recognized gains and losses offset amounts recognized in cost of services and products sold principally as a result of intercompany or third party foreign currency exposures.
Contracted Amounts of Foreign Currency Exchange Forward Contracts Outstanding at September 30, 2017:
(In thousands)
 
Type
 
U.S. Dollar
Equivalent
 
Maturity
 
Recognized
Gain (Loss)
British pounds sterling
 
Sell
 
$
70,207

 
October 2017
 
$
(807
)
British pounds sterling
 
Buy
 
10,638

 
October 2017 through January 2018
 
17

Euros
 
Sell
 
317,163

 
October 2017 through December 2017
 
(19,028
)
Euros
 
Buy
 
196,214

 
October 2017 through May 2018
 
792

Other currencies
 
Sell
 
50,692

 
October 2017 through April 2018
 
(758
)
Other currencies
 
Buy
 
30,578

 
October 2017 through January 2018
 
239

Total
 
 
 
$
675,492

 
 
 
$
(19,545
)
Contracted Amounts of Foreign Currency Exchange Forward Contracts Outstanding at December 31, 2016:
(In thousands)
 
Type
 
U.S. Dollar
Equivalent
 
Maturity
 
Recognized
Gain (Loss)
British pounds sterling
 
Sell
 
$
55,120

 
January 2017
 
$
(228
)
British pounds sterling
 
Buy
 
827

 
March 2017
 
(14
)
Euros
 
Sell
 
326,797

 
January 2017 through December 2017
 
628

Euros
 
Buy
 
171,578

 
January 2017 through January 2018
 
(468
)
Other currencies
 
Sell
 
43,455

 
January 2017 through September 2017
 
1,477

Other currencies
 
Buy
 
3,106

 
March 2017
 
(1
)
Total
 
 
 
$
600,883

 
 
 
$
1,394

 
Schedule of fair value of financial instruments
The following table indicates the fair value hierarchy of the financial instruments of the Company:
Level 2 Fair Value Measurements
(In thousands)
 
September 30
2017
 
December 31
2016
Assets
 
 

 
 

Foreign currency exchange forward contracts
 
$
3,245

 
$
4,932

Interest rate swaps
 
92

 

Cross-currency interest rate swaps
 
110

 
514

Liabilities
 
 

 
 

Foreign currency exchange forward contracts
 
22,790

 
3,538

Interest rate swaps
 
2,970

 

Schedule of the reconciliation of liabilities measured on a recurring basis using unobservable inputs
The following table reconciles the beginning and ending balances for liabilities measured on a recurring basis using unobservable inputs (Level 3):
Level 3 Liabilities—Unit Adjustment Liability (c) for the Nine Months Ended September 30
(In thousands)
 
Nine Months Ended
 
September 30
 
2016
Balance at beginning of period
 
$
79,934

Reduction in the fair value related to election not to make 2016 payments
 
(19,145
)
Sale of equity interest in Brand
 
(65,461
)
Change in fair value to the unit adjustment liability
 
4,672

Balance at end of period
 
$

(c)
During the quarter ended March 31, 2016, the Company decided that it would not make the four quarterly payments to CD&R for 2016. This resulted in the Company revaluing the Unit Adjustment Liability. The Company sold its investment in Brand in September 2016 and the unit adjustment liability ceased at that time. See Note 4, Equity Method Investment, for additional information related to the unit adjustment liability.